Human internal mammary artery organ culture model of coronary stenting: a novel investigation of smooth muscle cell response to drug-eluting stents.
Local drug delivery by coronary stents is of current research interest. Organ culture of human vascular tissue is a model of intimal hyperplasia. We report an ex vivo organ culture model of stented vessels. This allows stent-artery interactions to be studied in living tissue. The recognized anti-restenosis agent paclitaxel was chosen to test the organ culture model. Mammary artery specimens were cultured 'closed' (i.e. without opening them flat) for 72 h. Phosphocholine-coated stents, half of them loaded with the anti-restenosis drug paclitaxel, were implanted. The absorption and elution characteristics of paclitaxel were established. Artery tissue remained viable at 72 h when cultured closed, despite stent implantation. Specimens developed smooth muscle cell proliferation. The stents absorbed up to 127+/-29 microg of paclitaxel, with a biphasic elution curve. A mean of 13% of the absorbed paclitaxel remained after a 24 h perfusion. In mammary artery, these paclitaxel stents reduced or abolished smooth muscle cell proliferation compared with controls. This model allows the effects of stenting on human arterial tissue to be studied for at least 72 h, long enough to demonstrate effects on smooth muscle cell proliferation. Phosphocholine-coated stents absorb adequate doses of paclitaxel, which is eluted gradually, inhibiting muscle cell proliferation. Such an organ culture model of stented mammary artery will provide useful data in addition to that from animal or cell culture models of drug-eluting stents.
Swanson
Neil
N
Clinical Sciences Department, Glenfield Hospital, Leicester LE3 9QP, UK. ns56@le.ac.uk
Javed
Qamar
Q
Hogrefe
Kai
K
Gershlick
Anthony
A
D002455:Cell Division / Q000187:drug effects; D020099:Coated Materials, Biocompatible; D003324:Coronary Artery Disease / Q000473:pathology*; D016503:Drug Delivery Systems; D006083:Graft Occlusion, Vascular / Q000517:prevention & control; D006801:Humans; D008323:Mammary Arteries / Q000378:metabolism; D008955:Models, Cardiovascular; D009131:Muscle, Smooth, Vascular / Q000166:cytology / Q000378:metabolism*; D009924:Organ Culture Techniques / Q000379:methods; D017239:Paclitaxel / Q000493:pharmacokinetics*; D010767:Phosphorylcholine; D012008:Recurrence; D015607:Stents
D020099:Coated Materials, Biocompatible; D010767:Phosphorylcholine; D017239:Paclitaxel